CJC 1295 5 mg/Ipamorelin 5 mg CJC 1295 5 mg/Ipamorelin 5 mg
Peptide Hubs

CJC 1295 5 mg/Ipamorelin 5 mg

Product Details Peptide Hubs
Active Formula Per vial
Modified GRF (1–29)CJC-1295 No DAC · GHRH analogue
5 mg
IpamorelinGrowth hormone secretagogue
5 mg
Total Strength 10 mg/vial
Vial Size 2 mL vial
Form Lyophilized powder For reconstitution
Research Class GH-axis peptide blend
Primary Targets GHRH-R / GHSR
Ipamorelin Half-Life ~2 hours
Latest laboratory result 6.16 mg / 4.67 mg January 12, 2026 · 123.20% / 93.40% of label claim · Batch #GACJCIPA12 View
$78.00 $130.00
Shipping Location :
International
U.S. Domestic
Out of stock

Premium CJC-1295/Ipamorelin 10mg Blend by Peptide Hubs

Experience the powerful synergy of two exceptional growth hormone secretagogues with Peptide Hubs' CJC-1295/Ipamorelin 10mg blend. This advanced combination features 5mg of CJC-1295 and 5mg of Ipamorelin, meticulously formulated to maximize growth hormone release while minimizing unwanted side effects. Sourced from our trusted manufacturing facilities, this pharmaceutical-grade peptide complex represents the cutting edge of performance enhancement and body composition optimization.

Scientific Superiority of Combined Peptide Therapy

The strategic combination of CJC-1295 and Ipamorelin creates a powerful synergistic effect that surpasses what either peptide could achieve individually. CJC-1295, a synthetic analog of growth hormone-releasing hormone (GHRH) with Drug Affinity Complex (DAC) technology, binds to albumin in the bloodstream, significantly extending its half-life and providing sustained GH release. Meanwhile, Ipamorelin, a selective growth hormone secretagogue (GHS), works through the ghrelin receptor pathway to amplify pulsatile GH release without affecting cortisol or prolactin levels.

According to research published in the Oxford Academic, combination therapy with long-acting GHRH analogs and GHS peptides can produce sustained increases in IGF-1 levels and pulsatile growth hormone release that closely mimics natural secretion patterns. This scientific foundation makes the CJC-1295/Ipamorelin blend exceptionally effective for athletes seeking optimal body composition changes.

Benefits for Serious Athletes

Enhanced Muscle Growth

Promotes lean muscle development through increased IGF-1 production and protein synthesis without water retention.

Accelerated Fat Loss

Targets stubborn fat deposits, particularly abdominal fat, by enhancing lipolysis and metabolic rate.

Superior Recovery

Reduces recovery time between workouts by promoting cellular repair and reducing inflammation.

Improved Sleep Quality

Enhances deep sleep phases when administered before bedtime, maximizing natural GH pulses and recovery.

For those seeking alternative growth hormone support, consider our Hexarelin which offers powerful GH-releasing effects with a different mechanism of action.

Technical Details

Formula Type
Dual Peptide Blend
Research Pathways
GHRH + Ghrelin Receptor Signaling
CJC-1295 No DAC Sequence
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
CJC-1295 No DAC Length
29 Amino Acids
CJC-1295 No DAC Formula
C₁₅₂H₂₅₂N₄₄O₄₂
CJC-1295 No DAC Molecular Weight
3367.9 g/mol
CJC-1295 No DAC Target
GHRH Receptor Pathway
Ipamorelin Sequence
Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Ipamorelin Length
5 Residues
Ipamorelin Formula
C₃₈H₄₉N₉O₅
Ipamorelin Molecular Weight
711.9 g/mol
Ipamorelin Target
Ghrelin Receptor (GHSR)
Development Status
Investigational

Dosage & Usage Guidelines

Reconstitute the lyophilized powder with bacteriostatic water before administration. The typical dosage ranges from 100-300 mcg of the combined blend, administered 1-2 times daily. Most users experience optimal results with pre-bedtime administration to coincide with the body's natural nocturnal growth hormone surge. Some athletes benefit from an additional dose upon waking in a fasted state. The extended half-life of CJC-1295 allows for sustained effects between administrations.

For precise dosing, consider pairing with our sterile Bacteriostatic Water which is specifically formulated for peptide reconstitution and preservation.

Cycle Information and Stacking Options

Typical cycles range from 8-12 weeks, followed by a 4-week break to prevent desensitization. Many users report noticeable changes in body composition within the first 3-4 weeks, with continued improvements throughout the cycle. For enhanced results, the CJC-1295/Ipamorelin blend can be stacked with other peptides that complement its action.

Consider combining with TB-500 for accelerated injury recovery and enhanced connective tissue support, or with PEG-MGF for targeted muscle growth and repair.

Important: This product is intended for research purposes only. Not for human consumption. Always consult with a healthcare professional before beginning any new supplement regimen.

Why Choose Peptide Hubs' CJC-1295/Ipamorelin Blend?

Our CJC-1295/Ipamorelin combination undergoes rigorous third-party testing to ensure purity, potency, and sterility. Each batch is manufactured in ISO-certified facilities using pharmaceutical-grade ingredients and advanced lyophilization technology. The result is a premium peptide product that delivers consistent, measurable results for serious athletes.

For those interested in other peptide options, explore our Delta Sleep Inducing Peptide (DSIP) for improved sleep quality and stress reduction, or our GHK-Cu Copper Peptide for skin rejuvenation and tissue repair benefits.

Batch-Tested & Verified Lab Results

CJC-1295/Ipamorelin 10mg analytical report dated January 12, 2026, showing 10.83 mg
January 12, 2026 Latest Report
10.83 mg
Label Strength 10 mg
Assay vs Label 108.30%
View Report
CJC-1295/Ipamorelin 10mg analytical report dated September 29, 2025, showing 10.21 mg
September 29, 2025 Previous
10.21 mg
Label Strength 10 mg
Assay vs Label 102.10%
View Report

Shipping & Product Authenticity

USA Domestic
4–5 business days
International
13–15 business days
Order Processing
24–48 business hours
Tracking
Tracking number provided
Direct Supply & Discreet Delivery

This product is supplied through the official Peptide Hubs distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.

What to Expect

  • ✔ Orders are processed after payment confirmation
  • ✔ USA Domestic shipping is typically faster when local stock is selected
  • ✔ International orders include tracking, though update frequency may vary by destination
  • ✔ Multiple warehouses may result in separate shipments when applicable
Authenticity support: official Peptide Hubs presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
Verified Supply

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions

How does CJC-1295 differ from other GHRH analogs?

CJC-1295 features Drug Affinity Complex (DAC) technology that allows it to bind to albumin in the bloodstream, significantly extending its half-life to approximately 7-10 days. This creates sustained growth hormone release between administrations, unlike shorter-acting GHRH analogs that require more frequent dosing. The DAC modification also enhances stability and bioavailability compared to unmodified GHRH peptides.

When is the best time to administer this peptide blend?

The most effective administration time is before bedtime to coincide with your body's natural growth hormone pulse. Many users also benefit from a second dose upon waking in a fasted state. Avoid administering immediately after meals as elevated blood glucose can blunt the growth hormone response. The extended half-life of CJC-1295 means timing is less critical than with shorter-acting peptides, but consistency yields optimal results.

What results can I expect from using CJC-1295/Ipamorelin?

Users typically notice improved sleep quality and enhanced recovery within the first week. Visible fat loss, especially around the abdominal area, becomes apparent within 3-4 weeks. Full cycle results include significantly improved muscle definition, reduced body fat, enhanced recovery, improved skin texture, and increased lean muscle mass. The extended half-life of CJC-1295 provides more consistent results than shorter-acting peptide combinations.

Are there any side effects associated with this peptide blend?

CJC-1295/Ipamorelin is generally well-tolerated. Some users report temporary flushing, lightheadedness, or tingling sensations shortly after injection—these typically subside within 30 minutes. Unlike traditional GH therapy, this blend does not cause water retention, joint pain, or carpal tunnel syndrome. The selective action of Ipamorelin means it doesn't affect cortisol or prolactin levels, minimizing potential side effects.

How does this blend compare to Tesamorelin/Ipamorelin?

While both combinations are effective, CJC-1295/Ipamorelin offers extended activity due to the DAC technology in CJC-1295, providing more sustained growth hormone release between doses. Tesamorelin is specifically noted for its potent fat-loss effects, particularly on abdominal fat, while CJC-1295/Ipamorelin may offer more balanced benefits for both muscle growth and fat loss. The choice between them depends on individual goals and response patterns.

CJC 1295 5 mg/Ipamorelin 5 mg Reviews

P***r.
June 15, 2026

Works extremely well, although I did see an elevation in fasting glucose.

Please log in to write CJC 1295 5 mg/Ipamorelin 5 mg review.

Related Offers
Lab Tested
Domestic & International
-40% OFF
TB 500 5 mg/BPC 157 5 mg
Peptide Hubs
Product Details Peptide Hubs
Active Formula Per vial
Thymosin Beta-4β-Thymosin peptide
5 mg
BPC-157Synthetic pentadecapeptide
5 mg
Total Strength 10 mg/vial
Vial Size 2 mL vial
Form Lyophilized powder For reconstitution
Research Class Multi-peptide blend
Research Focus Tissue repair Regenerative research
Human PK Not established For combined formulation
Latest laboratory result 5.85 mg / 5.97 mg January 1, 2026 · 117.00% / 119.40% of label claim · Batch #GATBBPC12 View
$45.00 $75.00
You will save $30.00
Lab Tested
Domestic & International
-40% OFF
BPC 157 5 mg
Peptide Hubs
Product Details Peptide Hubs
Active Substance BPC-157 Body Protection Compound 157
Strength 5 mg/vial
Vial Size 2 mL vial
Form Lyophilized powder For reconstitution
Research Class Synthetic peptide
Peptide Length 15 amino acids Pentadecapeptide
Human Half-Life Not established
Development Status Investigational
Latest laboratory result 5.17 mg/vial October 1, 2025 · 103.40% of 5 mg label claim · Batch #BPCGA8 View
$22.80 $38.00
You will save $15.20

Add to Cart - Product(s)

Close Button
Empty

Total Cost: